CANNABIS-CBD & HEMP RESTRICT
HB2748 amends the Illinois Cannabis Regulation and Tax Act to tighten age restrictions and compliance rules for the sale of cannabis, cannabis-infused products, CBD, and hemp. The bill makes clear that these products may not be sold or transferred to anyone under 21, and it expands the under-21 restrictions to include possession, attempted purchase, and attempts to gain access using false or fraudulent age information, except where otherwise authorized by the medical cannabis law or the community college cannabis vocational training pilot program.
The bill also adds retailer compliance requirements. It requires dispensaries and other cannabis business establishments to verify age and identity using government-issued identification and electronic scanning or reading devices, and it imposes penalties on underage consumers who use false identification or otherwise violate the age rules. In addition, it creates escalating fines for retailers that do not maintain a training program covering minimum-age cannabis laws, and it specifies that employees who reasonably rely on valid-looking identification are protected from discipline or discharge in certain circumstances.
HB2748 would affect several sections of the Cannabis Regulation and Tax Act, including definitions, possession limits, underage possession and transfer rules, identification and false identification penalties, storage requirements, and dispensing procedures. It also removes an applicability provision tied to the Industrial Hemp Act, while continuing to reference hemp and CBD in the cannabis regulatory framework. The practical effect is to broaden and clarify enforcement authority over cannabis-adjacent products and to impose more detailed operational obligations on retailers and dispensaries.
Because there are no committee transcripts or recorded votes provided, there is no documented debate or formal sentiment history in the materials supplied. Based on the bill text alone, the measure appears to be framed as a public-health and youth-access restriction bill, with an emphasis on compliance, verification, and retailer accountability rather than expansion of cannabis access.
The main points of potential contention are likely to be the expanded restrictions on hemp and CBD sales to adults under 21, the added retailer training and penalty regime, and the increased enforcement burden on dispensaries and other sellers. Supporters would likely view the bill as strengthening age verification and preventing underage access, while opponents may argue that it overextends cannabis-style restrictions to hemp and CBD products and adds regulatory costs for businesses.
The bill would amend multiple provisions of the Cannabis Regulation and Tax Act, changing how Illinois regulates sales, possession, identification checks, storage, and dispensing of cannabis, cannabis-infused products, CBD, and hemp. It would impose new age-based prohibitions for persons under 21, create penalties for false identification and underage possession or attempted purchase, and add fines for retailers that fail to maintain a minimum-age compliance training program. It also removes an applicability provision relating to the Industrial Hemp Act, while leaving hemp and CBD within the bill’s regulatory scope for age-verification and sale restrictions.
No committee testimony or vote record is included, so there is no direct evidence of legislative support or opposition in the provided materials. The bill’s structure and caption suggest a public-safety and youth-protection rationale, with a generally restrictive posture toward cannabis, CBD, and hemp sales to minors and young adults. On that basis, the bill appears designed to appeal to lawmakers focused on enforcement and retailer compliance, though the absence of recorded debate means the level of support or controversy cannot be measured from the supplied context.
The most likely areas of contention are the bill’s extension of under-21 restrictions to CBD and hemp, the requirement that retailers implement and document a training program on minimum-age cannabis laws, and the new fines tied to compliance failures. Retailers and hemp/CBD stakeholders may object to the added operational burden and the inclusion of hemp products in cannabis-style age restrictions, while supporters are likely to emphasize stronger age verification, deterrence of false identification, and clearer enforcement tools for regulators and law enforcement.